PlainRecalls
ModerateClass IIOngoing

FDA Devices recall · Reported March 16, 2022

NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Distributed in boxes of 6 assay strips in individual pouches. Box, pouch and strips all labeled with product name, ref #, lot #, and expiration date.

A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product.

Recall #
Z-0738-2022
Affected scope
102 boxes
Initiated
January 21, 2022
Verify with FDA Devices →
View my saved recalls

NeuMoDx Molecular Inc recalled NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947… - a moderate-severity action.

NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947… was recalled by NeuMoDx Molecular Inc in March 16, 2022. Reason: A risk for product contamination was identified for the affected product lot. If used, there is an increased …. Check the official notice for the remedy. Verify recall #Z-0738-2022 with the FDA Devices before acting.

The recall

NeuMoDx Molecular Inc issued this moderate-severity FDA Devices recall-A risk for product contamination was identified for the affected product lot. If used, there is an increased ….

Moderate
severity level
Class II
classification
March 16, 2022
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-0738-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Devices action (record #Z-0738-2022) was formally reported on March 16, 2022, with the manufacturer initiating the action on January 21, 2022. It is classified under Moderate severity (Class II), with a current status of Ongoing. NeuMoDx Molecular Inc is listed as the recalling firm, operating out of Ann Arbor, MI. Federal records list the affected scope as 102 boxes.

The documented reason for this recall is: A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product. Distribution data in the federal record shows the product reached: US Nationwide distribution in the states of FL, MD, MI, NY.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 40,322 medical devices recalls on record

-1,00001,0002,0003,0004,000 20052008201120142017202020232026 1,248
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

102 boxes

Related Recalls

6

3 from same agency

Product description

NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Distributed in boxes of 6 assay strips in individual pouches. Box, pouch and strips all labeled with product name, ref #, lot #, and expiration date.

Reason for recall

A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Ongoing
Recall number Z-0738-2022
Date reported March 16, 2022
Date initiated January 21, 2022
Recalling firm NeuMoDx Molecular Inc
Firm location Ann Arbor, MI
Affected scope 102 boxes
Distribution US Nationwide distribution in the states of FL, MD, MI, NY.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-0738-2022) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Distributed in boxes of 6 assay strips in individual pouches. Box, pouch and strips all labeled with product name, ref #, lot #, and expiration date.. Recalled by NeuMoDx Molecular Inc. Units affected: 102 boxes.
Why was this product recalled?
A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 16, 2022. Severity: Moderate. Recall number: Z-0738-2022.
Where was the recalled product distributed?
Distribution: US Nationwide distribution in the states of FL, MD, MI, NY..
How do I check if my product is affected by a recall?
Check the product description and recall number (Z-0738-2022) against your product. Visit the official FDA Devices website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →

Browse all Medical Devices recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported March 16, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.